|
GLS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.541800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.728400E-01 |
| Normal-vs-Stage2 |
3.169700E-02 |
| Normal-vs-Stage3 |
9.815500E-02 |
| Normal-vs-Stage4 |
7.418300E-02 |
| Stage1-vs-Stage2 |
3.034100E-04 |
| Stage1-vs-Stage3 |
2.609800E-01 |
| Stage1-vs-Stage4 |
1.631820E-01 |
| Stage2-vs-Stage3 |
1.397920E-04 |
| Stage2-vs-Stage4 |
4.155800E-04 |
| Stage3-vs-Stage4 |
6.677600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.286600E-01 |
| Normal-vs-AfricanAmerican |
4.716200E-01 |
| Normal-vs-Asian |
1.432180E-01 |
| Caucasian-vs-AfricanAmerican |
8.305000E-01 |
| Caucasian-vs-Asian |
7.138400E-01 |
| AfricanAmerican-vs-Asian |
6.406200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.969200E-01 |
| Normal-vs-Female |
3.091600E-01 |
| Male-vs-Female |
6.794200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.008400E-02 |
| Normal-vs-Age(41-60Yrs) |
6.312600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.822000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.664800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.517600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.154400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.843200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.025400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.693400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.462840E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.035170E-01 |
| Classical-VS-Follicular |
1.62436730732907E-12 |
| Classical-VS-Other |
8.512000E-01 |
| Classical-VS-Normal |
2.743500E-02 |
| Tall-VS-Follicular |
2.42160003161018E-09 |
| Tall-VS-Other |
4.891200E-01 |
| Tall-VS-Normal |
1.523400E-03 |
| Follicular-VS-Other |
1.763620E-01 |
| Follicular-VS-Normal |
1.7469299999906E-05 |
| Other-VS-Normal |
7.033000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.804800E-01 |
| Normal-vs-N1 |
2.720300E-02 |
| N0-vs-N1 |
1.608900E-04 |
|
|
|
GLS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.541800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.728400E-01 |
| Normal-vs-Stage2 |
3.169700E-02 |
| Normal-vs-Stage3 |
9.815500E-02 |
| Normal-vs-Stage4 |
7.418300E-02 |
| Stage1-vs-Stage2 |
3.034100E-04 |
| Stage1-vs-Stage3 |
2.609800E-01 |
| Stage1-vs-Stage4 |
1.631820E-01 |
| Stage2-vs-Stage3 |
1.397920E-04 |
| Stage2-vs-Stage4 |
4.155800E-04 |
| Stage3-vs-Stage4 |
6.677600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.286600E-01 |
| Normal-vs-AfricanAmerican |
4.716200E-01 |
| Normal-vs-Asian |
1.432180E-01 |
| Caucasian-vs-AfricanAmerican |
8.305000E-01 |
| Caucasian-vs-Asian |
7.138400E-01 |
| AfricanAmerican-vs-Asian |
6.406200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.969200E-01 |
| Normal-vs-Female |
3.091600E-01 |
| Male-vs-Female |
6.794200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.008400E-02 |
| Normal-vs-Age(41-60Yrs) |
6.312600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.822000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.664800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.517600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.154400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.843200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.025400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.693400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.462840E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.035170E-01 |
| Classical-VS-Follicular |
1.62436730732907E-12 |
| Classical-VS-Other |
8.512000E-01 |
| Classical-VS-Normal |
2.743500E-02 |
| Tall-VS-Follicular |
2.42160003161018E-09 |
| Tall-VS-Other |
4.891200E-01 |
| Tall-VS-Normal |
1.523400E-03 |
| Follicular-VS-Other |
1.763620E-01 |
| Follicular-VS-Normal |
1.7469299999906E-05 |
| Other-VS-Normal |
7.033000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.804800E-01 |
| Normal-vs-N1 |
2.720300E-02 |
| N0-vs-N1 |
1.608900E-04 |
|
|
